Actively Recruiting
Study on Low-Dose Azacitidine to Prevent Kidney Damage After Cardiac Surgery in Adults with Acute Kidney Injury
Led by National Taiwan University Hospital · Updated on 2025-02-20
60
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of a drug called azacitidine to prevent the progression from acute kidney injury AKI to chronic kidney disease CKD. AKI is becoming more common worldwide and can lead to ongoing kidney damage and end-stage renal disease if untreated. This study focuses on AKI related to cardiac surgery, a common cause of AKI in intensive care units, and aims to address the lack of effective treatments for this condition by studying the effects of azacitidine on kidney repair and scarring processes. The study compares two groups of patients who develop AKI after cardiac surgery. One group will receive three doses of low-dose azacitidine through subcutaneous injections over one week, while the other group will receive placebo injections on the same schedule. Azacitidine is known for its demethylation effects and is already approved for certain blood cancers but is being tested here at a lower dose to reduce toxicity. After treatment, patients will be monitored regularly for kidney function and urine protein levels every three months. Participants will have their kidney function assessed through measurements such as estimated glomerular filtration rate eGFR and urine protein-creatinine ratio UPCR. The main outcomes include significant decline in kidney function, increased protein in urine, and development of end-stage renal disease. The study also tracks overall mortality and cardiovascular death over two years. Safety and effectiveness will be closely monitored during this period to understand azacitidines potential role in preventing kidney disease progression.
CONDITIONS
Brief Title
Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
Research Team
Y
Yu Hsiang Chou, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here